BindingDB logo
myBDB logout

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27075367 55 Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2.EBI BAYER Pharma AG
26101576 12 Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2.EBI AbbVie, Inc.
25406853 72 Selective inhibitors of protein methyltransferases.EBI Icahn School of Medicine at Mount Sinai
25746813 37 SAH derived potent and selective EZH2 inhibitors.EBI Pfizer Inc.
25032507 43 Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.EBI University of North Carolina at Chapel Hill
28135235 71 An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.BDB Novartis Institutes for BioMedical Research